Amy Thomas
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 9
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 5
- Pancreatic and Hepatic Oncology Research 3
- Colorectal Cancer Treatments and Studies 1
-
- Immunotherapy and Immune Responses 5
- Co-authors
- Elizabeth M. Jaffee (8 shared papers)Yi-Cheng Chen (1 shared paper)Ralph H. Hruban (1 shared paper)Michael Goggins (2 shared papers)Daniel A. Laheru (3 shared papers)Eric R. Lutz (1 shared paper)Todd D. Armstrong (1 shared paper)Xianzheng Zhou (2 shared papers)
- Journals
- Cancer Research (4 papers)Journal of Clinical Oncology (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Human Gene Therapy (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United States
In The Last Decade
Amy Thomas
10 papers receiving 381 citations
Peers
Comparison fields: 5 of 35
- Oncology 244
- Immunology 189
- Biotechnology 37
- Cancer Research 29
- Genetics 50
Countries citing papers authored by Amy Thomas
This map shows the geographic impact of Amy Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Thomas more than expected).
Fields of papers citing papers by Amy Thomas
This network shows the impact of papers produced by Amy Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Thomas. The network helps show where Amy Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 255 | |
| 2 | 2003 | 40 | |
| 3 | 2005 | 35 | |
| 4 | 2024 | 21 | |
| 5 | 2004 | 10 | |
| 6 | 2024 | 9 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 4 | |
| 10 | 2025 | 1 |
About Amy Thomas
Amy Thomas is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology and Genetics, having authored 10 papers that have together received 385 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers), Pancreatic and Hepatic Oncology Research (3 papers), Colorectal Cancer Treatments and Studies (1 paper), Cancer Research and Treatments (1 paper), Ferroptosis and cancer prognosis (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Oncology (244 citations), Immunology (189 citations), Biotechnology (37 citations), Cancer Research (29 citations) and Genetics (50 citations). Amy Thomas has collaborated with scholars based in United States. Frequent co-authors include Elizabeth M. Jaffee, Yi-Cheng Chen, Ralph H. Hruban, Michael Goggins, Daniel A. Laheru, Eric R. Lutz, Todd D. Armstrong, Xianzheng Zhou, Xin Huang and Drew M. Pardoll. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Human Gene Therapy and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.